Evaluation of educational intervention on awareness of adverse drug reaction reporting among geriatric population in a tier II city of India

Chaitali Tailor; Anupama Desai

doi:10.18203/2319-2003.ijbcp20233898

Authors

Chaitali Tailor Department of Pharmacology, Surat Municipal Institute of Medical Education and Research, Surat, Gujarat, India
Anupama Desai Department of Pharmacology, Surat Municipal Institute of Medical Education and Research, Surat, Gujarat, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20233898

Keywords:

Adverse drug reporting, Pharmacovigilance, Patient’s direct reporting, Public awareness

Abstract

Background: Adverse drug reactions in the geriatric population are a growing concern, given their susceptibility to medication-related complications. However, underreporting of ADRs remains a significant challenge in India. This study aimed to evaluate the impact of an educational intervention on ADR reporting awareness among the geriatric population in a Tier II city of India.

Methods: A pre-post intervention study was conducted in a Tier II city, involving a sample of geriatric individuals aged 60 and above. An educational intervention, consisting of workshops, pamphlets, and interactive sessions, was designed to enhance awareness of ADR reporting procedures. Pre-intervention and post-intervention assessments were conducted to measure changes in ADR reporting knowledge and willingness to report ADRs.

Results: A total of 71 responses were received. All participants demonstrated an increased understanding of the importance of reporting ADRs and were more willing to report such incidents to health care authorities after the intervention. The educational intervention significantly improved awareness of ADR reporting procedures among the geriatric population

Conclusions: The intention of the study was to assess the effectiveness of an educational programme on geriatric patients' awareness of the need to report adverse drug reactions to pharmacovigilance centres given that this age group is more prone to use multiple therapies. A large number of participants felt that increasing pharmacovigilance awareness and knowledge sharing will benefit society.

Metrics

Metrics Loading ...

References

Durrieu G, Jacquot J, Mège M, Bondon-Guitton E, Rousseau V, Montastruc F, et al. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. Drug Saf. 2016; 39(12):1189-1195.

Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2017;83(2): 227-246.

Adisa R, Adeniyi OR, Fakeye TO. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria. Int J Clin Pharm. 2019;41(4):1062-1073.

Al Dweik R, Stacey D, Kohen D, Yaya S. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4): 875-83.

van Hunsel F, de Waal S, Härmark L. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015. Pharmacoepidemiol Drug Saf. 2017;26(8):977-983.

Ribeiro-Vaz I, Silva AM, Costa Santos C, Cruz-Correia R. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2016;16:27.

Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf. 2011;34:187-97.

Steurbaut S, Hanssens Y. Pharmacovigilance: empowering healthcare professionals and patients. Int J Clin Pharm. 2014;36:859-62.

Sales I, Aljadhey H, Albogami Y, Mahmoud MA. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia. Saudi Pharm J. 2017;25(6):868-872.

Islam A, Al-Karasneh AF, Naqvi AA, Al-Shayban DM, Al-Hayek F, Al-Badrani S, et al. Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia. Pharmacy. 2020;8:222.

Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36(2):75-81.

Lorimer S, Cox A, Langford NJ. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting. J Clin Pharm Ther. 2012;37(2):148-52.

Krska J, Jones L, Mckinney J, Wilson C. Medicine safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098-103.

Matos C, Van Hunsel F, Joaquim J. Are consumers ready to take part in the Pharmacovigilance System? a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;71(7):883-90.